期刊文献+

骨质疏松治疗靶点:骨硬化蛋白及DKK-1与年龄、体质量指数、血糖和血脂之间的关系 被引量:9

Therapeutic targets of osteoporosis:correlation of age,body mass index,blood glucose and blood lipids with sclerostin and DKK-1
下载PDF
导出
摘要 背景:研究显示,破骨细胞通过抑制骨硬化蛋白的表达发挥促进骨生成的作用,而调控骨吸收和骨形成平衡的关键在于骨吸收过程抑制骨硬化蛋白表达的程度。目的:分析成年男性骨硬化蛋白、DKK-1与年龄、体质量指数、空腹血糖、血脂之间的关系。方法:筛选健康体检的成年男性70例,46-67岁;收集其年龄、身高、体质量和既往病史等相关信息。检测空腹血糖、血脂,ELISA的方法测定血清骨硬化蛋白及DKK-1水平。结果与结论:(1)不同年龄、体质量指数、空腹血糖的受试者血清骨硬化蛋白水平差异有显著性意义(P<0.05);年龄57-67岁受试者血清DKK-1水平显著高于年龄46-56岁者(P<0.05);(2)血清骨硬化蛋白与DKK-1之间不存在相关性;(3)多元线性回归分析显示血清骨硬化蛋白与空腹血糖、体质量指数显著相关,血清DKK-1与年龄显著相关。因此,在进行骨硬化蛋白和DKK-1的相关研究时,需关注年龄、体质量指数、空腹血糖的影响。 BACKGROUND:Chondrocytes have been shown to promote osteogenesis by inhibiting the expression of sclerostin.The key to regulating the balance between bone resorption and bone formation is sclerostin expression inhibition in the process of bone resorption.OBJECTIVE:To analyze the correlation of age,body mass index,fasting blood glucose(FBG)and serum lipid with sclerostin and DKK-1 in adult men.METHODS:Seventy healthy men aged 46-67 years who received physical examination were enrolled.Age,body height,body mass and medical history were collected.The FBG and blood lipids were detected.The serum levels of sclerostin and DKK-1 were detected by ELISA.RESULTS AND CONCLUSION:(1)The level of sclerostin was significantly different among participants with different ages,body mass indices and FBG levels(P<0.05).The serum level of DKK-1 in 57-67-year-old participants was significantly higher than that in 46-56-year-old participants(P<0.05).(2)There was no relationship between serum sclerostin and DKK-1 levels.(3)Multiple linear regression analysis showed that serum level of sclerostin was significantly associated with FBG and body mass index.Serum level of DKK-1 was significantly associated with age.Therefore,much attention should be paid to age,FBG and body mass index in studies on sclerostin and DKK-1.
作者 张树东 赵思聪 李世飞 周建 姚琦 Zhang Shu-dong;Zhao Si-cong;Li Shi-fei;Zhou Jian;Yao Qi(Department of Orthopedics,Beijing Shijitan Hospital,Capital Medical University,Beijing 100038,China;3Chinese PLA General Hospital,Beijing 100853,China;Department of Urology,Beijing Shijitan Hospital,Capital Medical University,Beijing 100038,China;Chinese PLA General Hospital,Beijing 100853,China)
出处 《中国组织工程研究》 CAS 北大核心 2018年第32期5085-5090,共6页 Chinese Journal of Tissue Engineering Research
基金 北京市科学技术委员会(Z151100003915094)~~
关键词 骨硬化蛋白 DKK-1 骨代谢 体质量指数 空腹血糖 血脂 组织构建 骨和骨组织 代谢 人体质量指数 血糖 骨质疏松 组织工程 Bone and Bones Metabolism Body Mass Index Blood Glucose Osteoporosis Tissue Engineering
  • 相关文献

参考文献2

二级参考文献34

  • 1Wongdee K, Charoenphandhu N. Osteoporosis in diabetesmellitus: Possible cellular and molecular mechanisms. World JDiabetes 2011; 2: 41-48 [PMID: 21537459 DOI: 10.4239/wjd.v2.i3.41].
  • 2Hofbauer LC, Brueck CC, Singh SK, Dobnig H. Osteoporosisin patients with diabetes mellitus. J Bone Miner Res 2007; 22:1317-1328 [PMID: 17501667 DOI: 10.1359/jbmr.070510].
  • 3Farr JN, Drake MT, Amin S, Melton LJ, McCready LK, KhoslaS. In vivo assessment of bone quality in postmenopausal womenwith type 2 diabetes. J Bone Miner Res 2014; 29: 787-795 [PMID:24123088 DOI: 10.1002/jbmr.2106].
  • 4Patsch JM, Burghardt AJ, Yap SP, Baum T, Schwartz AV, JosephGB, Link TM. Increased cortical porosity in type 2 diabeticpostmenopausal women with fragility fractures. J Bone Miner Res2013; 28: 313-324 [PMID: 22991256 DOI: 10.1002/jbmr.1763].
  • 5Pritchard JM, Giangregorio LM, Atkinson SA, Beattie KA,Inglis D, Ioannidis G, Punthakee Z, Adachi JD, Papaioannou A.Association of larger holes in the trabecular bone at the distalradius in postmenopausal women with type 2 diabetes mellituscompared to controls. Arthritis Care Res (Hoboken) 2012; 64:83-91 [PMID: 22213724 DOI: 10.1002/acr.20602].
  • 6Burghardt AJ, Issever AS, Schwartz AV, Davis KA, MasharaniU, Majumdar S, Link TM. High-resolution peripheral quantitativecomputed tomographic imaging of cortical and trabecular bonemicroarchitecture in patients with type 2 diabetes mellitus. J ClinEndocrinol Metab 2010; 95: 5045-5055 [PMID: 20719835 DOI:10.1210/jc.2010-0226].
  • 7Petit MA, Paudel ML, Taylor BC, Hughes JM, Strotmeyer ES,Schwartz AV, Cauley JA, Zmuda JM, Hoffman AR, Ensrud KE.Bone mass and strength in older men with type 2 diabetes: theOsteoporotic Fractures in Men Study. J Bone Miner Res 2010; 25:285-291 [PMID: 19594301 DOI: 10.1359/jbmr.090725].
  • 8Yamaguchi T, Kanazawa I, Yamamoto M, Kurioka S, YamauchiM, Yano S, Sugimoto T. Associations between components of themetabolic syndrome versus bone mineral density and vertebralfractures in patients with type 2 diabetes. Bone 2009; 45: 174-179[PMID: 19446053 DOI: 10.1016/j.bone.2009.05.003].
  • 9Lapmanee S, Charoenphandhu N, Aeimlapa R, Suntornsaratoon P,Wongdee K, Tiyasatkulkovit W, Kengkoom K, ChaimongkolnukulK, Seriwatanachai D, Krishnamra N. High dietary cholesterolmasks type 2 diabetes-induced osteopenia and changes in bonemicrostructure in rats. Lipids 2014; 49: 975-986 [PMID: 25200330DOI: 10.1007/s11745-014-3950-3].
  • 10Kengkoom K, Klinkhamhom A, Sirimontaporn A, Singha O,Ketjareon T, Panavechkijkul Y, Seriwatanachai D, Ukong S,Ampawong S. Effects on high cholesterol-fed to liver, retina,hippocampus, and Harderian gland in Goto-Kakizaki rat. Int J ClinExp Pathol 2013; 6: 639-649 [PMID: 23573310].

共引文献32

同被引文献105

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部